Vivacit-E Post-market Follow-up Study | MicrobiomeTrials← Back to trialsNCT03226808
Vivacit-E Post-market Follow-up Study
CompletedNAINTERVENTIONAL
Trial Details
Start: 2013-10-01Est. Completion: 2026-04-14
Enrollment target: 245 participants Locations- Denver Hip and Knee, Inc., Parker, Colorado, United States
- Department of Orthopaedics University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States
- OrthoCarolina Research Institute, Charlotte, North Carolina, United States
- Rothman Institute, Philadelphia, Pennsylvania, United States
- Texas Institute for Hip and Knee Surgery, Austin, Texas, United States
Other microbiome trials you might be interested in
Breast CancerAromatase InhibitorAromatase Inhibitor Induced Arthralgia
This is a pragmatic pilot trial designed to compare and evaluate the efficacy, safety, and cost-effectiveness of pharmac…
Daejeon, South KoreaEst. completion Dec 31, 2027
Total Knee Replacement
We are going to evaluate the difference between perioperative intravenous steroid supplementation, perioperative periart…
Lugano, SwitzerlandEst. completion Apr 30, 2027
Phase 3
Recruiting
This study is to evaluate the long-term safety, efficacy and tolerability of lorundrostat (an aldosterone synthase inhib…
Birmingham, United StatesEst. completion Dec 30, 2025